GRN and non-small cell lung carcinoma: Of special interest is that GP88 expression has been correlated with resistance to platinum-based chemotherapy in non-small cell lung cancer patients, and progranulin depletion sensitizes urothelial cancer cells to cisplatin treatment [16,34,37].